Browns linebacker Scott Fujita, a 10-year veteran and member of four NFL teams, has been in plenty of locker rooms, and he knows plenty of players. And so when it comes to gauging the prevalence of HGH in pro football, Fujita is in a better position to estimate than most. (He’s also a member of the NFLPA Executive Committee.)
Appearing on Friday night’s episode of NBC SportsTalk on VERSUS, Fujita pegged the usage of HGH at a surprisingly low number.
Fujita said that one to two percent of the players in the league use HGH, “at the most.”
Either way, the NFLPA has agreed that the players will submit to testing. The only question at this point is how the testing will be conducted.
Of course, that question could delay the implementation of testing indefinitely.
Fujita’s estimate gives rise to an even more important question. If the usage is as low as he believes it to be, why did the NFLPA agree to HGH testing at all?
The show airs again at 11:00 p.m. ET tonight. Or you can check out the pertinent clip below.